ID   BL41-K3
AC   CVCL_9667
SY   BL41/K3; BL41 K3; BL41K3
DR   EFO; EFO_0001091
DR   cancercelllines; CVCL_9667
DR   Wikidata; Q54797314
RX   PubMed=8553575;
RX   PubMed=8627226;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=8553575; DOI=10.1006/viro.1995.0084;
RA   Kempkes B., Pawlita M., Zimber-Strobl U., Eissner G., Laux G.,
RA   Bornkamm G.-W.;
RT   "Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion
RT   proteins transactivate viral and cellular genes and interact with
RT   RBP-J kappa in a conditional fashion.";
RL   Virology 214:675-679(1995).
//
RX   PubMed=8627226; DOI=10.1099/0022-1317-77-2-227;
RA   Kempkes B., Zimber-Strobl U., Eissner G., Pawlita M., Falk M.,
RA   Hammerschmidt W., Bornkamm G.-W.;
RT   "Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor
RT   fusion proteins complement the EBNA2-deficient Epstein-Barr virus
RT   strain P3HR1 in transformation of primary B cells but suppress growth
RT   of human B cell lymphoma lines.";
RL   J. Gen. Virol. 77:227-237(1996).
//